New Insights into the Therapeutic Efficacy of Nanomaterials
A special issue of Nanomaterials (ISSN 2079-4991). This special issue belongs to the section "Biology and Medicines".
Deadline for manuscript submissions: 15 September 2024 | Viewed by 87
Special Issue Editor
Interests: active drug targeting; biomedical applications of colloids and nanoparticles; biopharmacy; drug absorption; drug delivery; drug release; formulation and evaluation of pharmaceutical dosage forms; hyperthermia-based anticancer treatment; in vivo fate of nanoplatforms; ligand-receptor interactions and nanoparticle endocytosis; long-circulating nanoparticles; magnetic colloids; nanoteranosis; passive drug targeting; PEGylated nanoparticles; pharmaceutical technology; pharmacokinetics; stimuli sensitive nanostructures; surface chemistry and interface science; surface functionalization of nanoparticles
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Targeted therapies, based on multifunctional nanoparticles, have generated promising results in terms of optimized efficacy and reduced collateral toxicity. However, engineering nanoparticulate systems continues to encounter technical problems in vitro, e.g. reproducibility, the appropriate loading of active agents, or colloidal stability, to name only a few. Furthermore, biological barriers repersent important walls interfering with their successful in vivo fate. The blood–brain barrier, pleural fluid, and mucins on mucous membranes are among the most relevant barricades limiting the targeted delivery of nanomedicines. Recently, there has been significant progress in the optimization of the therapeutic efficacy of these nanomaterials.
This Special Issue of Nanomaterials hopes to receive contributions (in the form of research articles, letters, reviews and communications) that provide an update on the applications and perspectives associated with the engineering of therapeutically efficient nanomedicines. In addition, this Special Issue will analyze the barriers to drug delivery and provides an overview of the various approaches employed to address related topics.
I kindly invite you to contribute to this Special Issue of Nanomaterials entitled “New Insights into Therapeutic Efficacy of Nanomaterials”.
Prof. Dr. Jose L. Arias
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Nanomaterials is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- ligand-mediated delivery
- stimuli-sensitive nanomaterials
- image-guided drug delivery
- nanotheranosis
- biological barriers
- nanoparticles
- stimuli-sensitive nanomaterials
- passive drug targeting
- active drug targeting
